Mahan Ostadian, D.O
NPI 1821263005 · Pain Medicine (Anesthesiology) Physician · Austin, TX
Enrolled with Medicare as Practitioner - Interventional Pain Management · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1821263005
- Entity type
- Individual
- Primary specialty
- Pain Medicine (Anesthesiology) PhysicianAllopathic & Osteopathic Physicians
- Credential
- D.O
- Sex
- Male
- Sole proprietor
- No
- License
- M8231 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
18 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
2,070 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 723 | $120 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211 | 410 | $16 |
| Drug Test(s), Definitive, Utilizing (1) Drug Identification Methods Able to Identify Individual Drugs and Distinguish Between Structural Isomers (but Not Necessarily Stereoisomers), Including, But Not Limited to Gc/Ms (any Type, Single Or Tandem) and Lc/MsG0481 | 372 | $150 |
| Testing for Presence of Drug, Read By Direct Observation80305 | 100 | $12 |
| New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204 | 53 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 12 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Hydrocodone/Acetaminophenbrand: Hydrocodone-Acetaminophen | 839 | 212 |
| Oxycodone Hcl/Acetaminophenbrand: Oxycodone-Acetaminophen | 239 | 60 |
| Oxycodone Hcl | 175 | 47 |
| Fentanyl | 90 | 19 |
| Morphine Sulfatebrand: Morphine Sulfate Er | 57 | 14 |
| Gabapentin | 45 | 33 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$2,929 across 123 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2008-04-28
- Last updated
- 2010-06-28
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.